Skip to main content
. 2020 May;12(5):2877–2882. doi: 10.21037/jtd.2020.01.66

Figure 1.

Figure 1

Applications of non-invasive mutation detection for the initial genotyping and resistance monitoring on EGFR tyrosine kinase therapy.